Regulation of blood pressure and cardiovascular function by renalase

Kidney International

Volumn 76, Issue 4, 2009, Pages 366-370

  Desir, Gary V ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VACHS   (United States)

Author keywords

Amine oxidase; Blood pressure regulation; Catecholamine metabolism; Renal failure

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOLAMINE; RENALASE; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; ENZYME ACTIVITY; ENZYME RELEASE; GLOMERULUS FILTRATION RATE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; HUMANS; HYPERTENSION; MICE; MONOAMINE OXIDASE; RENAL INSUFFICIENCY, CHRONIC;

EID: 68249112138     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.169     Document Type: Short Survey

References (22)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Oberg BP, McMenamin E, Lucas FL et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016.
3. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004; 15: 524-537.
4. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004; 43: 699-706.
5. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
6. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
7. DiBona GF. Neural control of renal function: role of renal alpha adrenoceptors. J Cardiovasc Pharmacol 1985; 7 (Suppl 8): S18-S23.
8. DiBona GF. Neural control of renal function: cardiovascular implications. Hypertension 1989; 13: 539-548.
9. Hausberg M, Kosch M, Harmelink P et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-1979.
10. Converse Jr RL, Jacobsen TN, Toto RD et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-1918.
11. Klein IH, Ligtenberg G, Neumann J et al. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003; 14: 3239-3244.
12. Zoccali C, Mallamaci F, Tripepi G et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002; 40: 41-46.
13. Zoccali C, Mallamaci F, Parlongo S et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359.
14. Xu J, Li G, Wang P et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115: 1275-1280.
15. Li G, Xu J, Wang P et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 2008; 117: 1277-1282.
16. Ghosh SS, Krieg KJ, Sica DA et al. Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol 2009; 24: 367-377.
17. Wang J, Qi S, Cheng W et al. Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep 2008; 35: 613-620.
18. Boomsma F, Tipton KF. Renalase, a catecholamine-metabolising enzyme? J Neural Transm 2007; 114: 775-776.
19. Ghosh SS, Gehr TWB, Sica DA et al. Effect of renalase inhibition on blood pressure. J Am Soc Nephrology 2006; 17: 208A.
20. Desir GV, Wu Y, Wang P et al. Renalase deficiency increases sympathetic tone and causes hypertension. J Am Soc Nephrol 2008. Available at http://www.asn-online.org/education-and-meetings/renal-week/ archives/
21. Zhao Q, Fan Z, He J et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 2007; 85: 877-885.
22. Desir GV, Li Y, Liu D et al. Downregulation of cardiac renalase expression in CKD, and protective effect of renalase in acute coronary syndrome. J Am Soc Nephrol 2007; 18: 149A.